Free Trial

Empowered Funds LLC Acquires 15,019 Shares of Exelon Corporation $EXC

Exelon logo with Utilities background

Key Points

  • Empowered Funds LLC increased its stake in Exelon Corporation by 26.2%, owning 72,308 shares worth approximately $3.3 million after acquiring 15,019 additional shares.
  • Exelon reported earnings of $0.39 per share for the last quarter, exceeding the consensus estimate of $0.37, and has set FY 2025 guidance at 2.640-2.740 EPS.
  • The dividend declared by Exelon is $0.40 per share, providing a yield of 3.7%, with a payout ratio currently at 60.84%.
  • Interested in Exelon? Here are five stocks we like better.

Empowered Funds LLC boosted its stake in shares of Exelon Corporation (NASDAQ:EXC - Free Report) by 26.2% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 72,308 shares of the company's stock after purchasing an additional 15,019 shares during the period. Empowered Funds LLC's holdings in Exelon were worth $3,332,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Ameriflex Group Inc. purchased a new position in shares of Exelon in the fourth quarter valued at about $25,000. Hazlett Burt & Watson Inc. lifted its position in shares of Exelon by 46.4% in the first quarter. Hazlett Burt & Watson Inc. now owns 694 shares of the company's stock valued at $32,000 after acquiring an additional 220 shares in the last quarter. ANTIPODES PARTNERS Ltd purchased a new position in shares of Exelon in the first quarter valued at about $34,000. MJT & Associates Financial Advisory Group Inc. purchased a new position in shares of Exelon in the first quarter valued at about $42,000. Finally, Opal Wealth Advisors LLC purchased a new position in shares of Exelon in the first quarter valued at about $50,000. 80.92% of the stock is currently owned by hedge funds and other institutional investors.

Exelon Trading Down 1.6%

NASDAQ EXC traded down $0.70 during trading hours on Tuesday, hitting $42.73. 6,252,261 shares of the company were exchanged, compared to its average volume of 7,138,058. The stock has a 50-day moving average price of $44.01 and a 200 day moving average price of $44.20. The company has a quick ratio of 0.85, a current ratio of 0.95 and a debt-to-equity ratio of 1.66. Exelon Corporation has a 52 week low of $35.94 and a 52 week high of $48.11. The stock has a market cap of $43.16 billion, a PE ratio of 16.25, a price-to-earnings-growth ratio of 2.54 and a beta of 0.41.

Exelon (NASDAQ:EXC - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The company reported $0.39 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.02. Exelon had a return on equity of 9.85% and a net margin of 11.16%.The company had revenue of $5.43 billion for the quarter, compared to analysts' expectations of $5.47 billion. During the same period in the previous year, the firm posted $0.47 earnings per share. The firm's revenue for the quarter was up 1.2% on a year-over-year basis. Exelon has set its FY 2025 guidance at 2.640-2.740 EPS. Analysts forecast that Exelon Corporation will post 2.64 earnings per share for the current fiscal year.

Exelon Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, September 15th. Shareholders of record on Monday, August 11th were paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 3.7%. The ex-dividend date of this dividend was Monday, August 11th. Exelon's payout ratio is presently 60.84%.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the company. KeyCorp lowered their price objective on Exelon from $39.00 to $37.00 and set an "underweight" rating on the stock in a research report on Wednesday, July 16th. UBS Group reaffirmed a "neutral" rating and issued a $48.00 target price (up from $47.00) on shares of Exelon in a report on Friday, July 11th. Finally, Morgan Stanley reaffirmed an "outperform" rating on shares of Exelon in a report on Thursday, August 21st. Five analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $47.20.

View Our Latest Analysis on Exelon

Exelon Company Profile

(Free Report)

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.

Read More

Institutional Ownership by Quarter for Exelon (NASDAQ:EXC)

Should You Invest $1,000 in Exelon Right Now?

Before you consider Exelon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.

While Exelon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.